Emerging role of nanomedicine in the treatment of neuropathic pain.

Journal of Drug Targeting
Pankaj BidveVinod Tiwari

Abstract

Neuropathic pain (NeP) is a complex chronic pain condition associated with nerve injury. Approximately, 7-10% of the general population across the globe is suffering from this traumatic condition, but the existing treatment strategies are inadequate to deliver pain relief and are associated with severe adverse effects. To overcome these limitations, lot of research is focussed on developing new molecules with high potency and fewer side effects, novel cell and gene-based therapies and modification of the previously approved drugs by different formulation aspects. Nanomedicine has attracted a lot of attention in the treatment of many diverse pathological conditions because of their unique physiochemical and biological properties. In this manuscript, we highlighted the emerging role of nanomedicine in different therapies (drug, cell and gene), also we emphasised on the challenges associated with nanomedicine such as development of well-characterised nanoformulation, scaling of batches with reproducible results and toxicity along with this we discussed about the future of nanomedicine in the treatment of neuropathic pain.

References

Sep 9, 1986·European Journal of Pharmacology·E EspositoR Samanin
Oct 1, 1993·Neuropharmacology·R W Fuller, H D Snoddy
Apr 2, 1999·Science·M F PittengerD R Marshak
Jun 23, 2000·Pain·Jianren Mao, Lucy L Chen
Nov 5, 2002·Journal of Clinical Pharmacology·Tianling ChenAndrej Skerjanec
Dec 12, 2002·Molecular Biology of the Cell·Patricia A ZukMarc H Hedrick
Apr 16, 2003·Journal of Pain and Symptom Management·Norman Harden, Mitchell Cohen
Oct 9, 2003·The Journal of Urology·Yao-Chi ChuangMichael B Chancellor
Apr 24, 2004·The Journal of Pain : Official Journal of the American Pain Society·Ariel BergerGerry Oster
May 5, 2005·The European Journal of Neuroscience·Erin D MilliganLinda R Watkins
Oct 8, 2005·Particle and Fibre Toxicology·Günter OberdörsterUNKNOWN ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group
Nov 3, 2005·Environmental Health Perspectives·Marianne GeiserPeter Gehr
Nov 22, 2005·Expert Opinion on Drug Delivery·Thorsteinn LoftssonTomi Järvinen
Mar 23, 2007·Anesthesia and Analgesia·Markus KlassMarie Csete
Jun 7, 2007·Proceedings of the National Academy of Sciences of the United States of America·Anna K ClarkMarzia Malcangio
Jul 27, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·G TosiF Forni
Nov 15, 2007·Molecular Pharmaceutics·Preetha AnandBharat B Aggarwal
Jan 1, 2008·Small·Nastassja LewinskiRebekah Drezek
Jul 26, 2008·Nature Nanotechnology·Wendy R SanhaiMauro Ferrari
Jan 16, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Anne GardinSilke Appel-Dingemanse
May 26, 2009·Neurotoxicology·Larisa BelyanskayaPeter Wick
Jul 3, 2009·The Journal of Spinal Cord Medicine·Rishi S Nandoe TewarieMartin Oudega
May 28, 2010·The Oncologist·Miroslav Backonja, Clifford J Woolf
Jun 8, 2010·Journal of Biomedical Science·Chung-Ren LinYi-Shen Chen
Sep 8, 2010·Advanced Materials·Brian P TimkoDaniel S Kohane
Sep 21, 2010·Nature Neuroscience·Jason R ClapperDaniele Piomelli
Nov 17, 2010·European Journal of Clinical Pharmacology·Maria CusatoMario Regazzi
Jun 21, 2011·International Journal of Molecular Sciences·Houria BoulaizAntonia Aranega
Jul 19, 2011·Pain·Troels S JensenRolf-Detlef Treede
Jul 20, 2011·Journal of Polymer Science. Part B, Polymer Physics·Bret D UleryCato T Laurencin

❮ Previous
Next ❯

Citations

Mar 7, 2020·Molecular Pharmaceutics·Yaswanth KuthatiChih Shung Wong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pain Medicine : the Official Journal of the American Academy of Pain Medicine
Cory TothSamuel Wiebe
Cardiovascular & Hematological Disorders Drug Targets
Kannan Vaidyanathan, Sandhya Gopalakrishnan
Cleveland Clinic Journal of Medicine
Brian F Mandell
© 2022 Meta ULC. All rights reserved